Previous Article | Next Article ![]()
Journal of Clinical Microbiology, Jul 1995, 1704-1711, Vol 33, No. 7
JS Dumler, SM Chen, K Asanovich, E Trigiani, VL Popov and DH Walker
Ehrlichia chaffeensis is the causative agent of human monocytic
ehrlichiosis, a disease that ranges in severity from asymptomatic infection
to death. Only one isolate of E. chaffeensis has been made, the Arkansas
strain, upon which all characterizations of the agent of human monocytic
ehrlichiosis have been based. We report the isolation and characterization
of a new strain of E. chaffeensis, the 91HE17 strain, which was cultivated
from a patient with a nearly fatal illness. The new isolate grows best in
culture with careful control of pH. The two isolates are nearly identical
as determined by light and electron microscopy and have significant
antigenic identity in fluorescent-antibody and immunoblot assays using
polyclonal antisera and the E. chaffeensis-specific monoclonal antibody
1A9. Isolate 91HE17 had 99.9% nucleotide sequence identity with the
Arkansas strain in the 16S rRNA gene. Parts of the Escherichia coli GroE
operon homologs had identical restriction enzyme digestion patterns, and a
425-bp region of the GroEL gene had at least 99.8% sequence identity
between the E. chaffeensis Arkansas and 91HE17 strains. Isolate 91HE17
lacked an epitope identified in E. chaffeensis Arkansas by the monoclonal
antibody 6A1. This new E. chaffeensis isolate is very similar to the
Arkansas strain and provides the opportunity to substantiate the existence
of diversity among ehrlichiae which infect humans. Specific factors which
differ among strains may then be compared to assess their potential
contributions toward cellular pathogenicity and ultimately toward the
development of disease in humans.
Copyright © 1995 by the American Society for Microbiology. All rights reserved.
Isolation and characterization of a new strain of Ehrlichia chaffeensis from a patient with nearly fatal monocytic ehrlichiosis
Department of Pathology, University of Maryland Medical Center, Baltimore 21201, USA.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|